Beijing, China

Shannan Yu

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Shannan Yu: Innovator in Kinase Inhibitor Research

Introduction

Shannan Yu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of five patents to her name, her work is paving the way for new treatments in various medical conditions.

Latest Patents

Shannan Yu's latest patents include innovative compounds such as substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines. These compounds serve as inhibitors for kinases like TRK, c-MET, AXL, MER, and VEGFR2. The disclosed compounds exhibit strong inhibition activities and are intended for use in treating autoimmune diseases and cancers. Another notable patent involves oxazino-quinazoline and oxazino-quinoline type compounds, which also act as kinase inhibitors. These patents highlight her commitment to advancing medical science through innovative drug development.

Career Highlights

Shannan Yu is currently employed at Beijing Scitech-MQ Pharmaceuticals Limited. Her role at the company allows her to focus on research and development in the pharmaceutical sector. Her expertise in kinase inhibitors has positioned her as a key player in the industry, contributing to the advancement of therapeutic options for patients.

Collaborations

Shannan collaborates with esteemed colleagues such as Qiang Zhang and Leifu Yang. These partnerships enhance her research efforts and contribute to the innovative environment at her workplace.

Conclusion

Shannan Yu's work in the field of kinase inhibitors exemplifies her dedication to improving healthcare through innovation. Her patents and collaborations reflect her significant impact on pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…